Rating History for Amylin Pharmaceuticals (AMLN) by BMO Capital
| Date | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/2/2012 | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
28.20 | 30.98 | 9.86% | Details |
| 11/9/2011 | Upgrade | Outperform (N/A) |
17.00 (N/A) |
9.73 | 28.20 | 189.83% | Details |
| 9/8/2011 | New Coverage | Market Perform (N/A) |
12.00 (N/A) |
11.40 | 9.73 | -14.65% | Details |
| 3/4/2011 | Downgrade | Market Perform (N/A) |
N/A (N/A) |
11.20 | 11.40 | 1.79% | Details |
